Horizon Pharma Inc. (HZNP) announced that it intends to offer and sell units in an underwritten public offering, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock.
Horizon also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock and warrants to purchase shares of its common stock to cover overallotments, if any. All of the units in the offering are being offered by Horizon.
Cowen and Company, LLC, JMP Securities LLC and Stifel Nicolaus Weisel are acting as joint book-running managers for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
August 21, 2026 14:42 ET The minutes of the latest policy meeting of the Federal Reserve, housing market data and manufacturing sector survey results were the main news for the U.S. economy this week. In Europe, inflation data from the U.K. was the highlight, while consumer price data from Japan drew attention in Asia.